CHD-PAH and CTEPH patients with high levels of IL-8 at baseline showed a significantly reduced survival compared with IL-8low patients (p = 0.013 and p = 0.016, respectively; Fig. 2a). This evidence concerns the gene CXCL8 and pulmonary arterial hypertension.